Correlation Between BioNTech and Compass Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioNTech and Compass Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Compass Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and Compass Group PLC, you can compare the effects of market volatilities on BioNTech and Compass Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Compass Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Compass Group.

Diversification Opportunities for BioNTech and Compass Group

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between BioNTech and Compass is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Compass Group PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compass Group PLC and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Compass Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compass Group PLC has no effect on the direction of BioNTech i.e., BioNTech and Compass Group go up and down completely randomly.

Pair Corralation between BioNTech and Compass Group

Assuming the 90 days trading horizon BioNTech SE is expected to under-perform the Compass Group. In addition to that, BioNTech is 2.55 times more volatile than Compass Group PLC. It trades about -0.02 of its total potential returns per unit of risk. Compass Group PLC is currently generating about -0.03 per unit of volatility. If you would invest  3,003  in Compass Group PLC on April 23, 2025 and sell it today you would lose (95.00) from holding Compass Group PLC or give up 3.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BioNTech SE  vs.  Compass Group PLC

 Performance 
       Timeline  
BioNTech SE 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, BioNTech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Compass Group PLC 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Compass Group PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Compass Group is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

BioNTech and Compass Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioNTech and Compass Group

The main advantage of trading using opposite BioNTech and Compass Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Compass Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compass Group will offset losses from the drop in Compass Group's long position.
The idea behind BioNTech SE and Compass Group PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges